Area of research
Epidemiology · Cancer Research
Research interest
Research interests include Neuroendocrine Tumor Research Advances, Cancer, Hypoxia, and Metabolism, Monoclonal and Polyclonal Antibodies Research, and Neuroblastoma Research and Treatments.
Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model
Multimodal Imaging of 2-Cycle PRRT with <sup>177</sup>Lu-DOTA-JR11 and <sup>177</sup>Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo
Relationship of Renal Function in Mice to Strain, Sex and 177Lutetium-Somatostatin Receptor Ligand Treatment
Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer
CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer
Diffusion-weighted magnetic resonance imaging using a preclinical 1 T PET/MRI in healthy and tumor-bearing rats
CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance